Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Targeted cancer therapies often cause serious skin problems that need careful management.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

Monitoring for adverse effects in clinical treatments is crucial.

Dutasteride effectively treats enlarged prostate with manageable side effects.

ATP helps prevent skin damage from vandetanib by reducing stress.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

The consensus provides guidelines for safely stopping danazol in hereditary angioedema treatment.

Mesotherapy helps treat male hair loss effectively.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Combining fractional CO2 laser with topical dutasteride is more effective for treating male hair loss than using the laser alone.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

A dissolving microneedle patch with dutasteride offers effective, long-lasting hair loss treatment with fewer side effects.

Vitamin E in the diet might help protect against hair loss caused by the chemotherapy drug doxorubicin in rabbits.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Pulsed electric field treatment may help the immune system fight liver tumors.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Cetuximab can cause eyelash growth, which is rare but manageable.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Dutasteride microinfusion and microneedling both effectively treat male hair loss.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

Using tazarotene with GliSODin improves facial skin more than tazarotene alone.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.